Merck, a global healthcare company, has selected Reval’s software-as-a-service (SaaS) solution to support its foreign exchange (FX) and interest rate derivative portfolios. Merck and Schering-Plough merged in November 2009 to create a new company that today is the second-largest healthcare company in the world.
“We are thrilled to work with such a quality, global company on its initiative to bring together all of its processes for exposure management, derivative management and hedge accounting onto a single, integrated workflow using Reval,” said Jeff Stacey, Reval’s managing director, Americas.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.